4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-010207
Options or other derivatives
- Chief Legal Officer acquired 116,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Siegel Jolie Chief Legal Officer | 2022-02-14 | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | D | ||
| Siegel Jolie Chief Legal Officer | 2022-02-14 | Grant or award · Performance Restricted Stock Units | +26,250 | 26,250 | D | ||
Loading xslF345X03/doc4.xml…